GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ligand Pharmaceuticals Inc (STU:LGDN) » Definitions » Unearned Premiums

Ligand Pharmaceuticals (STU:LGDN) Unearned Premiums


View and export this data going back to 2013. Start your Free Trial

What is Ligand Pharmaceuticals Unearned Premiums?

Unearned Premiums only applies to insurance companies.


Ligand Pharmaceuticals (STU:LGDN) Business Description

Traded in Other Exchanges
Address
3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA, USA, 92121
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.